ConvaTec Group PLC (CTEC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ConvaTec Group PLC (CTEC) has a cash flow conversion efficiency ratio of 0.086x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX155.00 Million ≈ $18.86K USD) by net assets (GBX1.81 Billion ≈ $220.37K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ConvaTec Group PLC stock valuation for the company's overall valuation and market capitalisation.
ConvaTec Group PLC - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how ConvaTec Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ConvaTec Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ConvaTec Group PLC ranked by their cash flow conversion efficiency. Explore CTEC cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elron Electronic Industries Ltd
TA:ELRN
|
-0.005x |
|
Skyline Builders Group Holding Limited
NASDAQ:KAZR
|
-0.016x |
|
Pintaras Jaya Bhd
KLSE:9598
|
0.031x |
|
Broadwind Energy Inc
NASDAQ:BWEN
|
0.013x |
|
Nam Kwang Cons
KO:001260
|
-0.101x |
|
Mgame Corp
KQ:058630
|
-0.004x |
|
MEDIANA Co.Ltd
KQ:041920
|
-0.016x |
|
DURECT CORP. DL-001
F:DC8A
|
N/A |
Annual Cash Flow Conversion Efficiency for ConvaTec Group PLC (2013–2024)
The table below shows the annual cash flow conversion efficiency of ConvaTec Group PLC from 2013 to 2024. View latest ConvaTec Group PLC stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX1.69 Billion ≈ $205.49K |
GBX396.20 Million ≈ $48.21K |
0.235x | +8.08% |
| 2023-12-31 | GBX1.69 Billion ≈ $205.95K |
GBX367.40 Million ≈ $44.70K |
0.217x | +24.03% |
| 2022-12-31 | GBX1.61 Billion ≈ $195.85K |
GBX281.70 Million ≈ $34.27K |
0.175x | -3.04% |
| 2021-12-31 | GBX1.69 Billion ≈ $206.21K |
GBX305.90 Million ≈ $37.22K |
0.180x | -24.52% |
| 2020-12-31 | GBX1.67 Billion ≈ $203.28K |
GBX399.50 Million ≈ $48.61K |
0.239x | -7.10% |
| 2019-12-31 | GBX1.56 Billion ≈ $189.93K |
GBX401.80 Million ≈ $48.89K |
0.257x | +18.26% |
| 2018-12-31 | GBX1.62 Billion ≈ $196.77K |
GBX352.00 Million ≈ $42.83K |
0.218x | +8.18% |
| 2017-12-31 | GBX1.52 Billion ≈ $185.40K |
GBX306.60 Million ≈ $37.30K |
0.201x | +234.77% |
| 2016-12-31 | GBX1.25 Billion ≈ $151.63K |
GBX74.90 Million ≈ $9.11K |
0.060x | +113.11% |
| 2015-12-31 | GBX-218.80 Million ≈ $-26.62K |
GBX100.30 Million ≈ $12.20K |
-0.458x | -576.75% |
| 2014-12-31 | GBX-2.17 Billion ≈ $-264.59K |
GBX147.30 Million ≈ $17.92K |
-0.068x | +36.95% |
| 2013-12-31 | GBX-2.13 Billion ≈ $-259.46K |
GBX229.10 Million ≈ $27.87K |
-0.107x | -- |
About ConvaTec Group PLC
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more